Scoop has an Ethical Paywall
Living Cell Technologies - Latest News [Page 3]
LCT Presentation at American Diabetes Association
Monday, 28 June 2010, 1:23 pm | Living Cell Technologies
28 June 2010: Sydney, Australia & Auckland, New Zealand. Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), a global company pioneering the development of cell implants to treat diabetes, today announced that its DIABECELL® Phase I/IIa ... More >>
LCT Options Expiring 30th June 2010 Underwritten
Tuesday, 22 June 2010, 12:30 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), a global company pioneering the development of cell implants to treat diabetes, today announced the underwriting of 9.5m unlisted options which will add a minimum of $2.0 million to the Company’s ... More >>
Living Cell Technologies Receives Grant from JDRFI
Tuesday, 27 April 2010, 1:27 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL® in New Zealand from the Juvenile ... More >>
Living Cell Technologies’ Paper Best Of 2009
Tuesday, 13 April 2010, 2:05 pm | Living Cell Technologies
Living Cell Technologies Limited is pleased to announce that its publication on the use of encapsulated choroid plexus cells has been highlighted as one of the best articles published by the Journal of Neural Engineering in 2009. More >>
Encapsulation device registered in Russia
Wednesday, 10 March 2010, 1:32 pm | Living Cell Technologies
Cell implant company Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that its subsidiary LCT Biomedical Limited has received registration of the encapsulation device as a delivery system in Russia. More >>
LCT Grant To Advance Drug For Type 1 Diabetes
Friday, 12 February 2010, 1:26 pm | Living Cell Technologies
Cell implant company Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that it has been awarded a grant of NZ$4.04 million from the New Zealand government’s Foundation for Research Science & Technology. More >>
Living Cell Technologies Receives 10% of CytoSolv
Tuesday, 9 February 2010, 2:35 pm | Living Cell Technologies
Cell implant company Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that it has received 10% ownership of CytoSolv Inc. in exchange for restricted supply of choroid plexus cell clusters from its designated pathogen free pig herd ... More >>
Living Cell Technologies Granted European Patent
Wednesday, 20 January 2010, 2:28 pm | Living Cell Technologies
NTCELL targets neurological diseases such as Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis and Huntington’s disease and Stroke Patent based on technology of implanting encapsulated porcine choroid plexus cells Journal of Neural ... More >>
LCT Considers Australian Trials
Friday, 11 December 2009, 1:41 pm | Living Cell Technologies
10 December 2009: Sydney, Australia, Auckland, New Zealand – Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that it hopes to expand its clinical trial program into Australia, following the decision by the National Health and Medical ... More >>
Diabetes Patient Progressing Well
Friday, 4 December 2009, 12:09 pm | Living Cell Technologies
· In response to overwhelming public queries, clinician investigator reports progress on Living Cell Technologies’ (LCT’s) Diabetes Trial in New Zealand More >>
Living Cell Technologies; Share Purchase Plan
Monday, 16 November 2009, 1:30 pm | Living Cell Technologies
16 November 2009: Sydney, Australia, Auckland, New Zealand – Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) announced today a Share Purchase Plan (SPP) that would remain open until 11 December 2009. More >>
First Pig Cell Implant for Diabetes in NZ
Wednesday, 7 October 2009, 12:41 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that DIABECELL® was successfully implanted yesterday in the first patient with type 1 diabetes in Auckland, New Zealand. DIABECELL®, LCT’s encapsulated porcine cells that produce ... More >>
LCT appoints two new directors, new chair
Wednesday, 23 September 2009, 5:30 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced the appointment of Mr Bob Finder and Mr David McAuliffe as independent directors and the election of Dr David Brookes as chairman. More >>
Living Cell Technologies Company Announcement
Tuesday, 1 September 2009, 1:37 pm | Living Cell Technologies
Living Cell Technologies highlights its internationally leading technology at a meeting on Stem Cells and Cell Programming More >>
Living Cell Technologies Raises A$4.2m For Trials
Thursday, 30 July 2009, 1:00 pm | Living Cell Technologies
30 July 2009: Sydney, Australia, Auckland, New Zealand – Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) announced that it has closed a private placement of share capital raising A$4.2m. The placement provides for the issue of up to 25.5m ... More >>
Breakthrough for hearing loss treatment
Wednesday, 8 July 2009, 1:24 pm | Living Cell Technologies
Wednesday 8 July 2009: Sydney, Australia, Auckland, New Zealand– Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today reports that its encapsulated choroid plexus cells (NeurotrophinCell, NTCell) were shown to protect nerve cells in the inner ear ... More >>
DIABECELL® Commercialization Program In Russia
Monday, 6 July 2009, 12:42 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced the formation of a subsidiary, LCT Biomedical Limited (Russia), to facilitate the commercial development of DIABECELL®, its lead product for the treatment of type 1 diabetes. More >>
New NZ Pig Breeding Facility for Clinical Trials
Thursday, 2 July 2009, 12:14 pm | Living Cell Technologies
Living Cell Technologies Limited announced that its new designated pathogen free pig breeding facility in Invercargill, Southland, New Zealand was formally opened by the Mayor of Invercargill, Mr. Tim Shadbolt. The facility is designed to meet ... More >>
Clinical trial raises hope for diabetics
Wednesday, 24 June 2009, 2:27 pm | Living Cell Technologies
Wednesday June 24 2009: Sydney, Australia & Auckland, New Zealand – A clinical trial for a new treatment for type 1 diabetes which potentially eliminates the need for daily insulin injections will commence in New Zealand by Australian company Living ... More >>
Living Cell Technologies’ NZ Pigs Free of Viruses
Monday, 27 April 2009, 2:54 pm | Living Cell Technologies
27 April 2009 – Sydney, Australia, Auckland, New Zealand– Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today emphasized that its pig cell product, DIABECELL® presently in Phase I/IIa clinical trial for the treatment of insulin dependent diabetes, ... More >>
